What are the advantages and disadvantages of using IV opioids as monotherapy outside the context of multimodal therapy, where other agents are used in conjunction as part of ERAS?

What are the advantages and disadvantages of using IV opioids as monotherapy outside the context of multimodal therapy, where other agents are used in conjunction as part of ERAS?

What are the advantages and disadvantages of using IV opioids as monotherapy outside the context of multimodal therapy, where other agents are used in conjunction as part of ERAS? What are the downsides of this approach?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Jeff Gadsden, MD

Jeff Gadsden, MD

Associate Professor
Duke University School of Medicine
Chief, Division of Orthopaedic, Plastic and Regional Anesthesiology
Duke University Medical Center
Chapel Hill, North Carolina